Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model. 2018

Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Center of Respiratory Medicine of Fujian Province, Quanzhou 362000, China.

BACKGROUND Hepatic cytochrome P450 (CYP) isoforms, CYP1A2, is one of important enzymes for many drugs metabolism. Studies have confirmed that sustained hypoxia can influence the expression of hepatic CYP, including CYP1A2. The impact of chronic intermittent hypoxia (CIH), a marked characteristic of sleep apnea, on CYP1A2 remains unclear. The aim of the present study was to evaluate the effect of CIH on the expression of hepatic CYP1A2 in a mouse model with sleep apnea. METHODS Twenty four old male (6-8 weeks) C57BL/6J mice (n=12 in each group) were randomly assigned to either normoxia group or CIH group. Mice in CIH group underwent 12 weeks intermittent hypoxia exposure. The different gene expression of hepatic CYP1A2 between two groups was analyzed by quantity real-time polymerase chain reaction. The protein levels of hepatic CYP1A2 in each group were observed by using western blotting and immunohistochemistry. RESULTS After 12 weeks of exposure to intermittent hypoxia, the expression of hepatic CYP1A2, at the mRNA and protein levels was decreased more significantly in the CIH group than the normoxia group (P<0.01). CONCLUSIONS CIH contributes to inhibiting the expression of hepatic CYP1A2. This implies that the dosage of drugs metabolized by CYP1A2, should be adjusted in patients with sleep apnea.

UI MeSH Term Description Entries

Related Publications

Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
May 2020, Journal of thoracic disease,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
August 2012, Phytotherapy research : PTR,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
January 2017, PloS one,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
July 2017, Molecular medicine reports,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
November 2017, Chinese medical journal,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
April 2001, Biochemical pharmacology,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
January 2004, Breast cancer research : BCR,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
November 2005, European journal of clinical pharmacology,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
May 2010, Drug metabolism and disposition: the biological fate of chemicals,
Xiao-Bin Zhang, and Yi-Ming Zeng, and Xiao-Yang Chen, and Yi-Xiang Zhang, and Jin-Zhen Ding, and Cheng Xue
July 2000, Molecular psychiatry,
Copied contents to your clipboard!